Skip to main content
AKBA $0.42 +3.28%
AKBA logo
AKBA · Akebia Therapeutics, Inc.
Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M
All webcasts

Earnings call · FY2020 Q2

Akebia Therapeutics, Inc. (AKBA) Q2 2020 Earnings Call

Concluded Aug 10, 2020
Aug 10, 2020
Period
FY2020 Q2
Runtime
—
Sources
2 artifacts
Revenue $90.14M -10.6% YoY
Diluted EPS -$1.28
Gross margin · derived Q4 -93.7% -156.3 pp YoY
Net income -$175.75M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License Collaboration and Other Revenue$59.45M -17.1% YoY
Product$30.70M +5.5% YoY
Full-screen source Call document